Psychedelics offer new therapeutic framework for stress-related psychiatric disorders
Peer-Reviewed Publication
Updates every hour. Last Updated: 18-Oct-2025 16:11 ET (18-Oct-2025 20:11 GMT/UTC)
A comprehensive peer-reviewed viewpoint published in Psychedelics examines how psychedelic substances could transform treatment approaches for stress-related psychiatric disorders. Xiaohui Wang from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, analyze neurobiological mechanisms including serotonin 2A receptor activation, neuroplasticity enhancement, and inflammation reduction. The authors propose psychedelics address root causes rather than symptoms alone, offering hope for treatment-resistant conditions.
The same chemical reaction that makes a piece of freshly toasted bread delicious also happens in our bodies, with far less appetizing consequences. We’re talking about the Maillard reaction, where sugars react with protein to form brown, sticky compounds in a process called glycation. Glycation is increasingly suspected to be a hidden driver of obesity, diabetes and accelerated aging. Researchers in the Kapahi lab have found a way to tame it in mice by feeding them a combination of glycation-lowering compounds.
The University of Osaka scientists have developed a safe, efficient “dump-and-stir” method to introduce ortho-carborane into various aromatic compounds using a newly designed lithium–copper reagent. This innovation overcomes the complexity and hazards of previous methods, paving the way for new applications in boron neutron capture therapy (BNCT), three-dimensional aromatic materials, and bioisosteric drug design.